Safety of a mRNA COVID-19 Vaccine in Patients with Indolent Systemic Mastocytosis

Safety of a mRNA COVID-19 Vaccine in Patients with Indolent Systemic Mastocytosis

N/a.

Bibliographic Details
Main Authors:	Joana Gouveia, Maria Alexandra Rodrigues, Iolanda Fernandes, Renata Cabral, Helena Falcão
Format:	Article
Language:	English
Published:	Ordem dos Médicos 2024-03-01
Series:	Acta Médica Portuguesa
Subjects:	COVID-19/immunology COVID-19 Vaccines Mastocytosis, Systemic/immunology RNA, Messenger
Online Access:	https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/20851

Similar Items

A case of indolent systemic mastocytosis responding to treatment with Avapritinib
by: Terrence Sun, et al.
Published: (2024-02-01)

Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine
by: Brock Kingstad-Bakke, et al.
Published: (2023-11-01)

Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases
by: Roya M. Dayam, et al.
Published: (2022-06-01)

Mastocytosis in the Skin: Disease Heterogeneity among Children and Adults
by: Christos Fokoloros, et al.
Published: (2023-01-01)

Delayed Diagnosis of Indolent Systemic Mastocytosis as the Cause of Unexplained Skin Rash: A Case Report
by: Awni Alshurafa, et al.
Published: (2023-02-01)

Systemic Lymphadenopathic Mastocytosis with Eosinophilia
by: Soyoung Im, et al.
Published: (2022-12-01)

Cutaneous Mastocytosis in Childhood—Update from the Literature
by: Florica Sandru, et al.
Published: (2021-04-01)

Urticaria pigmentosa and systemic mastocytosis
by: Jonathan Keow, et al.
Published: (2023-12-01)

Balance between maternal antiviral response and placental transfer of protection in gestational SARS-CoV-2 infection
by: Juliana Gonçalves, et al.
Published: (2023-09-01)

IL-13 is a driver of COVID-19 severity
by: Alexandra N. Donlan, et al.
Published: (2021-08-01)

Single-epitope T cell–based vaccine protects against SARS-CoV-2 infection in a preclinical animal model
by: Takuya Tada, et al.
Published: (2023-04-01)

T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
by: Asia-Sophia Wolf, et al.
Published: (2023-06-01)

Longitudinal single-cell analysis of SARS-CoV-2–reactive B cells uncovers persistence of early-formed, antigen-specific clones
by: Lydia Scharf, et al.
Published: (2023-01-01)

Cross-reactivity of SARS-CoV-2– and influenza A–specific T cells in individuals exposed to SARS-CoV-2
by: Worarat Chaisawangwong, et al.
Published: (2022-09-01)

COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune response
by: John F. McDyer, et al.
Published: (2023-05-01)

Mild/asymptomatic COVID-19 in unvaccinated pregnant mothers impairs neonatal immune responses
by: Brianna M. Doratt, et al.
Published: (2023-10-01)

Key patient demographics shape innate immune topography in noncritical hypoxic COVID-19 pneumonia
by: Allison C. Billi, et al.
Published: (2023-08-01)

Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
by: Siriruk Changrob, et al.
Published: (2023-04-01)

The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2–associated multisystem inflammatory syndrome in children
by: Mehdi Benamar, et al.
Published: (2023-01-01)

Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody
by: Tanushree Dangi, et al.
Published: (2022-12-01)

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses
by: Sydney I. Ramirez, et al.
Published: (2022-12-01)

Health care worker seromonitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration
by: Sigrid Gouma, et al.
Published: (2021-08-01)

Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
by: Alberto Cagigi, et al.
Published: (2021-11-01)

In-depth analysis of SARS-CoV-2–specific T cells reveals diverse differentiation hierarchies in vaccinated individuals
by: Li Li, et al.
Published: (2022-04-01)

Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection
by: Rachel M. Gittelman, et al.
Published: (2022-05-01)

Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responses
by: Jacob K. Files, et al.
Published: (2021-08-01)

Favorable vaccine-induced SARS-CoV-2–specific T cell response profile in patients undergoing immune-modifying therapies
by: Martin Qui, et al.
Published: (2022-06-01)

PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response
by: Cristian Loretelli, et al.
Published: (2021-12-01)

Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza
by: Seppe Cambier, et al.
Published: (2022-01-01)

Mastocytosis in Pregnancy
by: Ilknur Col Madendag, et al.
Published: (2010-06-01)

Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients
by: Leonardo Sorrentino, et al.
Published: (2023-03-01)

Venom immunotherapy in indolent systemic mastocytosis with high serum tryptase level
by: Ali Selcuk, et al.
Published: (2021-06-01)

Genome-Wide DNA Methylation and Gene Expression in Patients with Indolent Systemic Mastocytosis
by: Aleksandra Górska, et al.
Published: (2023-09-01)

Occurrence of Unexpected Adverse Reactions to Vaccines in Children with Mastocytosis
by: Hanna Abuhay, et al.
Published: (2020-03-01)

Mastocytosis—A Review of Disease Spectrum with Imaging Correlation
by: Ahmed Elsaiey, et al.
Published: (2021-10-01)

Systemic mastocytosis in Croatia
by: Ivan Krečak, et al.
Published: (2022-10-01)

Diffuse Cutaneous Mastocytosis: A Current Understanding of a Rare Disease
by: Agnieszka Rydz, et al.
Published: (2024-01-01)

Gastrointestinal Manifestations in a Child With Mastocytosis
by: Gholamhossein Fallahi, et al.
Published: (2019-01-01)

Humoral Response Following Triple Dose of mRNA Vaccines Against SARS-CoV-2 in Hemodialysis Patients: Results After 1 Year of Follow-Up
by: Eduardo Gallego-Valcarce, et al.
Published: (2022-07-01)

Systemic Mastocytosis Associated with “Smoldering” Multiple Myeloma
by: Magda Zanelli, et al.
Published: (2021-01-01)